{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:48:09Z","timestamp":1791488889625,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41591-025-03511-2","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:14:52Z","timestamp":1740132892000},"page":"1276-1285","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Telemedicine-based integrated management of atrial fibrillation in village clinics: a cluster randomized trial"],"prefix":"10.1038","volume":"31","author":[{"given":"Ming","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodongqin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiafeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhirong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8755-6965","authenticated-orcid":false,"given":"Mingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-486X","authenticated-orcid":false,"given":"Minglong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the MIRACLE-AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"3511_CR1","unstructured":"Communiqu\u00e9 of the Seventh National Population Census Vol. 2024 (National Bureau of Statistics of China, 2021)."},{"key":"3511_CR2","doi-asserted-by":"publisher","first-page":"102759","DOI":"10.1016\/j.cpcardiol.2024.102759","volume":"49","author":"M Li","year":"2024","unstructured":"Li, M. et al. Is it high time to leave the chronic disease care of rural older people to village doctors in China: insights from a population-based atrial fibrillation screening study. Curr. Probl. Cardiol. 49, 102759 (2024).","journal-title":"Curr. Probl. Cardiol."},{"key":"3511_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1186\/s12889-023-16161-1","volume":"23","author":"Y-R Du","year":"2023","unstructured":"Du, Y.-R. et al. Ethnic disparities in prevalence of chronic non-communicable diseases and its multimorbidity among older adults in rural southwest China. BMC Public Health 23, 1217 (2023).","journal-title":"BMC Public Health"},{"key":"3511_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/hec.1306","volume":"17","author":"K Eggleston","year":"2008","unstructured":"Eggleston, K., Ling, L., Qingyue, M., Lindelow, M. & Wagstaff, A. Health service delivery in China: a literature review. Health Econ. 17, 149\u2013165 (2008).","journal-title":"Health Econ."},{"key":"3511_CR5","unstructured":"Anon. The orientation of the revolution in medical education as seen in the growth of barefoot doctor. Red Flag 3, 20\u201326 (1968)."},{"key":"3511_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccep.2020.10.010","volume":"13","author":"J Zhang","year":"2021","unstructured":"Zhang, J., Johnsen, S. P., Guo, Y. & Lip, G. Y. H. Epidemiology of atrial fibrillation: geographic\/ecological risk factors, age, sex, genetics. Card. Electrophysiol. Clin. 13, 1\u201323 (2021).","journal-title":"Card. Electrophysiol. Clin."},{"key":"3511_CR7","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","volume":"120","author":"L Staerk","year":"2017","unstructured":"Staerk, L., Sherer, J. A., Ko, D., Benjamin, E. J. & Helm, R. H. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circ. Res. 120, 1501\u20131517 (2017).","journal-title":"Circ. Res."},{"key":"3511_CR8","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/VHRM.S379182","volume":"18","author":"M Li","year":"2022","unstructured":"Li, M. et al. Screening for atrial fibrillation by village doctors in rural areas of China: the Jiangsu Province Rural Community AF Project. Vasc. Health Risk Manag. 18, 757\u2013766 (2022).","journal-title":"Vasc. Health Risk Manag."},{"key":"3511_CR9","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.jacc.2020.01.052","volume":"75","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. Mobile health technology to improve care for patients with atrial fibrillation. J. Am. Coll. Cardiol. 75, 1523\u20131534 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"3511_CR10","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(17)32165-7","volume":"390","author":"D Vinereanu","year":"2017","unstructured":"Vinereanu, D. et al. A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial. Lancet 390, 1737\u20131746 (2017).","journal-title":"Lancet"},{"key":"3511_CR11","doi-asserted-by":"publisher","first-page":"i2003","DOI":"10.1136\/bmj.i2003","volume":"353","author":"J Han","year":"2016","unstructured":"Han, J., Wu, M.-C. & Yang, T. Challenge of China\u2019s rural health. BMJ 353, i2003 (2016).","journal-title":"BMJ"},{"key":"3511_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-4491-11-17","volume":"11","author":"H Xu","year":"2013","unstructured":"Xu, H. et al. Longitudinal study of rural health workforce in five counties in China: research design and baseline description. Hum. Resour. Health 11, 17 (2013).","journal-title":"Hum. Resour. Health"},{"key":"3511_CR13","unstructured":"The Plan for \u2018Health China 2030\u2019 Vol. 2017 (CPC Central Committee, State Council, 2016)."},{"key":"3511_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0041-1739411","volume":"122","author":"T-F Chao","year":"2022","unstructured":"Chao, T.-F. et al. 2021 Focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary. Thromb. Haemost. 122, 20\u201347 (2022).","journal-title":"Thromb. Haemost."},{"key":"3511_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1055\/a-2325-5923","volume":"124","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. 2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary. Thromb. Haemost. 124, 897\u2013911 (2024).","journal-title":"Thromb. Haemost."},{"key":"3511_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks, G. et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 42, 373\u2013498 (2021).","journal-title":"Eur. Heart J."},{"key":"3511_CR17","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","volume":"14","author":"GYH Lip","year":"2017","unstructured":"Lip, G. Y. H. The ABC pathway: an integrated approach to improve AF management. Nat. Rev. Cardiol. 14, 627\u2013628 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"3511_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jacasi.2024.07.006","volume":"4","author":"M Li","year":"2024","unstructured":"Li, M. et al. A novel model of integrated care of older patients with atrial fibrillation in rural China. JACC Asia 4, 764\u2013773 (2024).","journal-title":"JACC Asia"},{"key":"3511_CR19","first-page":"1947","volume":"103","author":"C Gallagher","year":"2017","unstructured":"Gallagher, C. et al. Integrated care in atrial fibrillation: a systematic review and meta-analysis. Heart 103, 1947\u20131953 (2017).","journal-title":"Heart"},{"key":"3511_CR20","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jacasi.2023.04.008","volume":"3","author":"T Bucci","year":"2023","unstructured":"Bucci, T. et al. Integrated care for atrial fibrillation using the ABC pathway in the prospective APHRS-AF registry. JACC Asia 3, 580\u2013591 (2023).","journal-title":"JACC Asia"},{"key":"3511_CR21","doi-asserted-by":"publisher","first-page":"qcae039","DOI":"10.1093\/ehjqcco\/qcae039","volume":"24","author":"R Krittayaphong","year":"2024","unstructured":"Krittayaphong, R., Chichareon, P., Methavigul, K., Treewaree, S. & Lip, G. Y. H. Relation of changes in ABC pathway compliance status to clinical outcomes in patients with atrial fibrillation: a report from the COOL-AF registry. Eur. Heart J. Qual. Care Clin. Outcomes 24, qcae039 (2024).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"3511_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1055\/s-0043-1772773","volume":"124","author":"S Treewaree","year":"2024","unstructured":"Treewaree, S., Lip, G. Y. H. & Krittayaphong, R. Non-vitamin K antagonist oral anticoagulant, warfarin, and ABC pathway adherence on hierarchical outcomes: win ratio analysis of the COOL-AF registry. Thromb. Haemost. 124, 69\u201379 (2024).","journal-title":"Thromb. Haemost."},{"key":"3511_CR23","doi-asserted-by":"crossref","unstructured":"Writing Committee Members et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 83, 109\u2013279 (2024).","DOI":"10.1016\/j.jacc.2023.08.017"},{"key":"3511_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40256-019-00356-2","volume":"20","author":"G Montalescot","year":"2020","unstructured":"Montalescot, G. et al. Educational impact on apixaban adherence in atrial fibrillation (the AEGEAN study): a randomized clinical trial. Am. J. Cardiovasc. Drugs 20, 61\u201371 (2020).","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"3511_CR25","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/eurheartj\/ehz666","volume":"41","author":"EPJP Wijtvliet","year":"2020","unstructured":"Wijtvliet, E. P. J. P. et al. Nurse-led vs. usual-care for atrial fibrillation. Eur. Heart J. 41, 634\u2013641 (2020).","journal-title":"Eur. Heart J."},{"key":"3511_CR26","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1093\/eurheartj\/ehaa055","volume":"41","author":"CJ van den Dries","year":"2020","unstructured":"van den Dries, C. J. et al. Integrated management of atrial fibrillation in primary care: results of the ALL-IN cluster randomized trial. Eur. Heart J. 41, 2836\u20132844 (2020).","journal-title":"Eur. Heart J."},{"key":"3511_CR27","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1093\/eurheartj\/ehs071","volume":"33","author":"JML Hendriks","year":"2012","unstructured":"Hendriks, J. M. L. et al. Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. Eur. Heart J. 33, 2692\u20132699 (2012).","journal-title":"Eur. Heart J."},{"key":"3511_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0140-6736(14)61992-9","volume":"385","author":"S Stewart","year":"2015","unstructured":"Stewart, S. et al. Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial. Lancet 385, 775\u2013784 (2015).","journal-title":"Lancet"},{"key":"3511_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejim.2022.11.002","volume":"107","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Mobile health-technology integrated care in atrial fibrillation patients with heart failure: a report from the mAFA-II randomized clinical trial. Eur. J. Intern. Med. 107, 46\u201351 (2023).","journal-title":"Eur. J. Intern. Med."},{"key":"3511_CR30","doi-asserted-by":"publisher","first-page":"e2140071","DOI":"10.1001\/jamanetworkopen.2021.40071","volume":"4","author":"Y Yao","year":"2021","unstructured":"Yao, Y., Guo, Y. & Lip, G. Y. H.; mAF-App II Trial Investigators. The effects of implementing a mobile health-technology supported pathway on atrial fibrillation-related adverse events among patients with multimorbidity: the mAFA-II randomized clinical trial. JAMA Netw. Open 4, e2140071 (2021).","journal-title":"JAMA Netw. Open"},{"key":"3511_CR31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s11739-023-03249-0","volume":"18","author":"Y Guo","year":"2023","unstructured":"Guo, Y. et al. Mobile health-technology integrated care in secondary prevention atrial fibrillation patients: a post-hoc analysis from the mAFA-II randomized clinical trial. Intern. Emerg. Med. 18, 1041\u20131048 (2023).","journal-title":"Intern. Emerg. Med."},{"key":"3511_CR32","doi-asserted-by":"publisher","first-page":"afac245","DOI":"10.1093\/ageing\/afac245","volume":"51","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Mobile health technology integrated care in older atrial fibrillation patients: a subgroup analysis of the mAFA-II randomised clinical trial. Age Ageing 51, afac245 (2022).","journal-title":"Age Ageing"},{"key":"3511_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1055\/a-1515-9630","volume":"122","author":"GF Romiti","year":"2022","unstructured":"Romiti, G. F. et al. Adherence to the \u2018Atrial fibrillation Better Care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients. Thromb. Haemost. 122, 406\u2013414 (2022).","journal-title":"Thromb. Haemost."},{"key":"3511_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff, C. T. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383, 955\u2013962 (2014).","journal-title":"Lancet"},{"key":"3511_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jacasi.2022.05.005","volume":"2","author":"C-E Chiang","year":"2022","unstructured":"Chiang, C.-E. et al. Stroke prevention in atrial fibrillation: a scientific statement of JACC: Asia (part 1). JACC Asia 2, 395\u2013411 (2022).","journal-title":"JACC Asia"},{"key":"3511_CR36","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","volume":"107","author":"TJ Wang","year":"2003","unstructured":"Wang, T. J. et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107, 2920\u20132925 (2003).","journal-title":"Circulation"},{"key":"3511_CR37","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1093\/eurheartj\/ehi694","volume":"27","author":"Y Miyasaka","year":"2006","unstructured":"Miyasaka, Y. et al. Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades. Eur. Heart J. 27, 936\u2013941 (2006).","journal-title":"Eur. Heart J."},{"key":"3511_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jchf.2016.09.016","volume":"5","author":"A Pandey","year":"2017","unstructured":"Pandey, A. et al. Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation. JACC Heart Fail. 5, 44\u201352 (2017).","journal-title":"JACC Heart Fail."},{"key":"3511_CR39","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1136\/heartjnl-2020-318648","volume":"107","author":"C Weber","year":"2021","unstructured":"Weber, C. et al. Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation. Heart 107, 1320\u20131326 (2021).","journal-title":"Heart"},{"key":"3511_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/eurheartj\/ehq491","volume":"32","author":"EJ van den Bos","year":"2011","unstructured":"van den Bos, E. J. et al. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur. Heart J. 32, 611\u2013617 (2011).","journal-title":"Eur. Heart J."},{"key":"3511_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/1521-4036(200008)42:4<457::AID-BIMJ457>3.0.CO;2-J","volume":"42","author":"K-J Lui","year":"2000","unstructured":"Lui, K.-J. A note on the log-rank test in life table analysis with correlated observations. Biom. J. 42, 457\u2013470 (2000).","journal-title":"Biom. J."},{"key":"3511_CR42","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1002\/sim.7145","volume":"35","author":"S Kalia","year":"2016","unstructured":"Kalia, S., Klar, N. & Donner, A. On the estimation of intracluster correlation for time-to-event outcomes in cluster randomized trials. Stat. Med. 35, 5551\u20135560 (2016).","journal-title":"Stat. Med."},{"key":"3511_CR43","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/ehjqcco\/qcad055","volume":"10","author":"EM Camacho","year":"2024","unstructured":"Camacho, E. M. & Lip, G. Y. H. Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040. Eur. Heart J. Qual. Care Clin. Outcomes 10, 326\u2013333 (2024).","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"3511_CR44","doi-asserted-by":"crossref","unstructured":"Diggle, P. J., Heagerty, P., Liang, K.-Y. & Zeger, S. Analysis of Longitudinal Data 2nd edn (Oxford Univ. Press, 2002).","DOI":"10.1093\/oso\/9780198524847.001.0001"},{"key":"3511_CR45","unstructured":"Hayes, R. J. & Moulton, L. H. Cluster Randomised Trials 2nd edn (Chapman & Hall\/CRC, 2017)."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03511-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03511-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:37:50Z","timestamp":1744810670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-025-03511-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["3511"],"URL":"https:\/\/doi.org\/10.1038\/s41591-025-03511-2","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.Y.H.L. is a consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Daiichi-Sankyo and Anthos. No fees are received personally. He is a National Institute for Health and Care Research (NIHR) senior investigator and co-principal investigator of the AFFIRMO project on multimorbidity in AF (grant agreement no. 899871), TARGET project on digital twins for personalized management of AF and stroke (grant agreement no. 101136244) and ARISTOTELES project on artificial intelligence for the management of chronic long-term conditions (grant agreement no. 101080189), which are all funded by the European Union\u2019s Horizon Europe research and innovation program. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}